Three integrated layers process raw clinical data into actionable diagnostic signals — in minutes, not days.
Connects directly to your PACS, LIS, EHR, and genomic sequencing outputs via HL7 FHIR and DICOM APIs. No manual data entry. No custom integration work required.
Purpose-built models trained on 2.4 million de-identified oncology cases. Supports 14 cancer types across imaging, pathology, and molecular biomarker analysis.
Clinician-facing dashboards present risk scores, key biomarker flags, and recommended next steps — embedded directly in your existing EMR workflow.
Most AI tools are built by engineers who have never seen a tumor board. Pegasi was co-developed with oncologists at MD Anderson and Dana-Farber. Every feature, every UI decision, every output format was validated against real clinical workflows before shipping.
That means zero learning curve for your clinical staff. If your oncologist has used an EMR, they can use Pegasi from day one.
Pegasi currently supports diagnostic assistance across 14 cancer types, with new models added quarterly.
Patient data security is non-negotiable. Pegasi is built from the ground up for healthcare's strictest compliance requirements.
Full Business Associate Agreement available. All PHI encrypted at rest and in transit.
Independently audited security controls covering availability, confidentiality, and processing integrity.
End-to-end encryption for all data transfers. Zero plaintext patient data stored on inference servers.
Granular user permissions, SSO/SAML integration, and complete audit logging for every data access event.
Schedule a 45-minute live demo with our clinical team. We'll show you exactly how Pegasi performs on cases similar to your patient population.
Request a Demo